1. Home
  2. PAVS vs TLSA Comparison

PAVS vs TLSA Comparison

Compare PAVS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • TLSA
  • Stock Information
  • Founded
  • PAVS 2004
  • TLSA 2013
  • Country
  • PAVS United States
  • TLSA United Kingdom
  • Employees
  • PAVS N/A
  • TLSA N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVS Health Care
  • TLSA Health Care
  • Exchange
  • PAVS Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • PAVS 90.2M
  • TLSA 87.8M
  • IPO Year
  • PAVS 2019
  • TLSA 2000
  • Fundamental
  • Price
  • PAVS $1.36
  • TLSA $0.68
  • Analyst Decision
  • PAVS
  • TLSA
  • Analyst Count
  • PAVS 0
  • TLSA 0
  • Target Price
  • PAVS N/A
  • TLSA N/A
  • AVG Volume (30 Days)
  • PAVS 12.2K
  • TLSA 1.2M
  • Earning Date
  • PAVS 01-01-0001
  • TLSA 02-18-2025
  • Dividend Yield
  • PAVS N/A
  • TLSA N/A
  • EPS Growth
  • PAVS N/A
  • TLSA N/A
  • EPS
  • PAVS N/A
  • TLSA N/A
  • Revenue
  • PAVS $6,544,819.00
  • TLSA N/A
  • Revenue This Year
  • PAVS N/A
  • TLSA N/A
  • Revenue Next Year
  • PAVS N/A
  • TLSA N/A
  • P/E Ratio
  • PAVS N/A
  • TLSA N/A
  • Revenue Growth
  • PAVS N/A
  • TLSA N/A
  • 52 Week Low
  • PAVS $0.32
  • TLSA $0.41
  • 52 Week High
  • PAVS $2.52
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 56.61
  • TLSA 38.37
  • Support Level
  • PAVS $1.31
  • TLSA $0.65
  • Resistance Level
  • PAVS $1.38
  • TLSA $0.70
  • Average True Range (ATR)
  • PAVS 0.05
  • TLSA 0.08
  • MACD
  • PAVS -0.01
  • TLSA -0.01
  • Stochastic Oscillator
  • PAVS 50.00
  • TLSA 3.97

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: